By KATIE THOMAS and CHARLES ORNSTEIN
Some hospital executives and cancer researchers sit on the boards of publicly traded companies, raising questions about whether their dual roles create a conflict of interest.
Published: December 30, 2018 at 07:00PM
from NYT Health https://nyti.ms/2EVPKoK
via IFTTT
from WordPress http://bit.ly/2EXyrDC
via IFTTT